San Francisco Neuroscience →
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
Serial Entrepreneur and Investor
Software Engineer at Skelmir
Vice President for Research at UT Health Science Center at San Antonio
Medical College of Wisconsin director of research commercialization
CEO of Foundry
Founder and Managing Director of DEV
November 19, 2019 · San Francisco
Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
From Our Editors · Special Report
Key indicators & expert insight from industry leaders
Sponsored · Whitepaper
What the most successful life sciences fundraising pitch decks all have in common
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.